chorionic gonadotrophin
intervet australia pty limited - gonadotrophin-chorionic - unknown - gonadotrophin-chorionic hormone-gonadotrophin active 0.0 - active constituent
orion temozolomide
orion laboratories (nz) ltd - temozolomide 100mg - capsule - 100 mg - active: temozolomide 100mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma
orion temozolomide
orion laboratories (nz) ltd - temozolomide 140mg - capsule - 140 mg - active: temozolomide 140mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma
orion temozolomide
orion laboratories (nz) ltd - temozolomide 180mg - capsule - 180 mg - active: temozolomide 180mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma
orion temozolomide
orion laboratories (nz) ltd - temozolomide 20mg - capsule - 20 mg - active: temozolomide 20mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma
orion temozolomide
orion laboratories (nz) ltd - temozolomide 250mg - capsule - 250 mg - active: temozolomide 250mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma
orion temozolomide
orion laboratories (nz) ltd - temozolomide 5mg - capsule - 5 mg - active: temozolomide 5mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint green sb-4020 titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma
orion ranitidine 150mg tablet blister pack
orion laboratories pty ltd t/a perrigo australia - ranitidine hydrochloride -
orion hexachlorophane 3% cleansing lotion hexachlorophene 30mg/g lotion bottle
orion laboratories pty ltd t/a perrigo australia - hexachlorophene, quantity: 30 mg/g - lotion - excipient ingredients: sodium lauryl sulfate; citric acid; methyl hydroxybenzoate; ethanol; purified water; dibasic sodium phosphate heptahydrate; fragrance (perfume); glycerol; cocamide dea; coconut oil; diethanolamine - disinfection of skin.
orion diazepam rectal solution 5 mg / 5 ml
orion laboratories pty ltd t/a perrigo australia - diazepam -